AAME
Atlantic American Corporation
There isn't enough reported data to score AAME yet.
MS
Morgan Stanley
MS's fundamentals are strong: revenue grew 16% and earnings per share grew 29%. At 15x earnings, it's trading in line with its usual 14x. Analysts expect earnings growth.
AAME Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
AAME's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like AAME.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
AAME PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 4.3x | $1.19 | — |
| Cheap | 5.4x | $1.51 | +27% |
| Fair | 14x | $3.87 | +225% |
| Expensive | 34x | $9.41 | +690% |
Historical ranges are pointers, not guarantees.
AAME has the edge over MS in the historical PE scenario, which offers more potential upside but is not a forecast.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
AAME Forward outlook
There aren't enough analyst estimates for AAME to show an outlook.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
AAME Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | $0.28 | +$0.51 |
| Q3 2025 | $0.21 | +$0.56 |
| Q2 2025 | $0.09 | +$0.26 |
| Q1 2025 | -$0.10 | -$0.05 |
| Q4 2024 | -$0.23 | -$0.20 |
| Q3 2024 | -$0.35 | -350% |
| Q2 2024 | -$0.17 | -950% |
| Q1 2024 | -$0.05 | +$0.10 |
MS has the stronger earnings trend. Trailing diluted EPS is up 22% for AAME versus MS up 29%.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS's earnings per share have climbed steadily: $12.60 over the past year, up 29% from the year before, and higher year over year for 10 quarters in a row.
AAME Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $51.3M | +4.5% |
| Q3 2025 | $53.8M | +21% |
| Q2 2025 | $55.3M | +16% |
| Q1 2025 | $50.1M | +6.7% |
| Q4 2024 | $49M | +4.9% |
| Q3 2024 | $44.5M | -0.2% |
| Q2 2024 | $47.7M | -3.1% |
| Q1 2024 | $47M | +1.6% |
MS has the stronger quarterly revenue trend. Revenue is up 4.5% for AAME versus up 12% for MS.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | 3.3% | +2.2 points |
| Q3 2025 | 1.4% | +6.9 points |
| Q2 2025 | 7.6% | +9.4 points |
| Q1 2025 | 2.1% | +7.4 points |
| Q4 2024 | 1.1% | +7.8 points |
| Q3 2024 | -5.5% | -10 points |
| Q2 2024 | -1.8% | -6.3 points |
| Q1 2024 | -5.3% | -1.4 points |
AAME's operating margin was 3.3% last quarter, up 2.2 points from the same quarter a year ago.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS's revenue has grown year over year for 14 quarters in a row: $20.3B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS's operating margin was 32% last quarter, down 1.2 points from the same quarter a year ago.
AAME Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | $17.7M | +86% |
| Q3 2025 | $6.6M | +11298% |
| Q2 2025 | $9.1M | +2423% |
| Q1 2025 | -$986K | +$4.4M |
| Q4 2024 | $9.5M | +54% |
| Q3 2024 | $58K | -96% |
| Q2 2024 | $361K | -95% |
| Q1 2024 | -$5.4M | +$6.3M |
AAME has the stronger cash trend. Its trailing FCF is up 504% versus its history, compared with MS at down 492%.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
AAME Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +1K shares |
| 1 year | 0% | -2K shares |
| 3 years | 0% | +8K shares |
| 5 years | -6.5% | -1.4M shares |
| Available history | -5.3% | -1.1M shares |
AAME has 20M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | — |
| Q3 2019 | — |
| Q2 2019 | $22,000 |
| Q1 2019 | $49,000 |
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over AAME on shareholder dilution, with a more favorable share count trend.
AAME Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2025 | -4.7x | Net Cash |
| Q3 2025 | -4.4x | Net Cash |
| Q2 2025 | -11.6x | Net Cash |
| Q4 2023 | -290.6x | Net Cash |
| Q3 2023 | -4.5x | Net Cash |
| Q2 2023 | -13.3x | Net Cash |
| Q4 2022 | -9.0x | Net Cash |
| Q3 2022 | -4.1x | Net Cash |
AAME has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like AAME.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
AAME Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.3 | Neutral |
| Stochastic | 16.6 | Oversold |
AAME's weekly RSI is 37 (neutral) and its Stochastic is 17 (oversold).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
AAME PE vs Financial Services Sector
| Metric | AAME | Sector median | Relative |
|---|---|---|---|
| PE | 4.3x | 13x | 67% below |
| PE % | 5 | 63 | 58 pts below |
AAME has the edge over MS on valuation relative to its sector.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
AAME Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.18 | 0.8% above |
| 20 week MA | $1.36 | 13% below |
| 50 week MA | $2.04 | 42% below |
| 100 week MA | $2.08 | 43% below |
| 200 week MA | $2.05 | 42% below |
AAME has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 42% below its 200-week average.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS has the edge over AAME on trend strength, trading above more of its moving averages.
AAME Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.85 | $2.08 | +12% |
| 2021 | $2.08 | $3.21 | +54% |
| 2022 | $3.21 | $2.42 | -25% |
| 2023 | $2.42 | $2.45 | +1.2% |
| 2024 | $2.45 | $1.48 | -40% |
| 2025 | $1.48 | $2.55 | +72% |
| 2026 YTD | $2.55 | $1.19 | -53% |
AAME is down 53% so far in 2026, after finishing higher in four of the previous six years.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has the edge over AAME on returns for 2026, with the stronger performance.